Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
Open Access
- 1 February 2014
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 383 (9917), 603-613
- https://doi.org/10.1016/s0140-6736(13)61950-9
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT ABreast Cancer Research and Treatment, 2012
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Methods for Equivalence and Noninferiority TestingTransplantation and Cellular Therapy, 2009
- Targeted Intraoperative Radiotherapy Impairs the Stimulation of Breast Cancer Cell Proliferation and Invasion Caused by Surgical WoundingClinical Cancer Research, 2008
- Full Dose Intraoperative Radiotherapy With Electrons (ELIOT) During Breast Conserving Surgery - Experience with 1246 Casesecancermedicalscience, 2008
- A mathematical model of breast cancer development, local treatment and recurrenceJournal of Theoretical Biology, 2007
- Cumulative Incidence in Competing Risks Data and Competing Risks Regression AnalysisClinical Cancer Research, 2007
- Non-inferiority trials: the ‘at least as good as’ criterion with dichotomous dataStatistics in Medicine, 2005
- Does breast cancer exist in a state of chaos?European Journal of Cancer, 1999
- Multicentricity and recurrence of breast cancerThe Lancet, 1997